Source comparison
Nutrobal: Growth Hormone Secretagogue Comparison
The following table compares Nutrobal to common peptide-based growth hormone secretagogues used in research settings. Focusing on administration route, dosing frequency, receptor mechanism, and practical lab considerations. | Compound | Administration Route |
This comparison does not assign a generated winner or score.
- The following table compares Nutrobal to common peptide-based growth hormone secretagogues used in research settings. Focusing on administration route, dosing frequency, receptor mechanism, and practical lab considerations.
- | Compound | Administration Route | Effective Half-Life | Primary Receptor Target | Storage Requirements | Typical Research Dosing | Professional Assessment ||—|—|—|—|—|—|| Nutrobal (MK-677) | Oral | ~24 hours (daily dosing) | Ghrelin (GHSR-1a) agonist | Room temperature stable | 10–30mg once daily | Best for long-duration studies requiring oral compliance; appetite stimulation is pronounced || Ipamorelin | Subcutaneous injection | ~2 hours | GHRH receptor agonist | 2–8°C refrigerated after reconstitution | 200–300mcg 2–3× daily | Precise growth hormone pulse control; requires multiple daily injections and cold storage || CJC-1295 (No DAC) | Subcutaneous injection | ~30 minutes | GHRH receptor agonist | 2–8°C refrigerated after reconstitution | 100–200mcg 2–3× daily | Short-acting; often stacked with ghrelin agonists for synergistic effect || Sermorelin | Subcutaneous injection | ~10–20 minutes | GHRH receptor agonist | 2–8°C refrigerated after reconstitution | 200–500mcg before sleep